At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,015,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hospitalization, Mortality Rates and Costs Associated With Chronic Obstructive Pulmonary Disease (COPD) in Distrito Federal, Brazil, Before and After the Change in 2018 State COPD Protocol Version - Real-world Data
In Brief
An observational study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 3,015,000 participants across 1 site.
Detailed Summary
This study evaluates hospitalizations and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD) before and after the implantation of a new COPD treatment plan (replacement of tiotropium soft mist inhaler for glycopyrronium dry powder inhaler) by the Health State Secretariat of Federal District in Brazil.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartApr 2021
Primary CompletionJul 2021
First PostedSep 2023
TodayJul 2026
First PostedSep 25, 2023
Enrollment StartApr 1, 2021
Primary CompletionJul 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.8 years ago